Correction: CMTM6 overexpression confers trastuzumab resistance in HER2‑positive breast cancer

Mol Cancer. 2024 Jan 5;23(1):3. doi: 10.1186/s12943-023-01918-4.

¹ Department of Oncology, Innovative Cancer Drug Research and Engineering Center of Liaoning Province, Cancer Stem Cell and Translation Medicine Lab, Shengjing Hospital of China Medical University, Shenyang, 110022, China.
² Department of Oncology, Innovative Cancer Drug Research and Engineering Center of Liaoning Province, Cancer Stem Cell and Translation Medicine Lab, Shengjing Hospital of China Medical University, Shenyang, 110022, China. liucg@sj-hospital.org.

No abstract available

Publication types